FEV₁ as a Standalone Spirometric Predictor and the Attributable Fraction for Death in Older Persons

References

1. 1.↵
   1. Miller MR,
   2. Hankinson J,
   3. Brusasco V,
   4. Burgos F,
   5. Casaburi R,
   6. Coates A,
   7. et al

   . Standardisation of spirometry. Eur Respir J 2005;26(1):319–338.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Pellegrino R,
   2. Viegi G,
   3. Brusasco V,
   4. Crapo RO,
   5. Burgos F,
   6. Casaburi R,
   7. et al

   . Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948–968.

   OpenUrlFREE Full Text
3. 3.↵
   1. Stanojevic S,
   2. Wade A,
   3. Stocks J,
   4. Hankinson J,
   5. Coates AL,
   6. Pan H,
   7. et al

   . Reference ranges for spirometry across all ages. Am J Respir Crit Care Med 2008;177(3):253–260.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Quanjer PH,
   2. Stanojevic S,
   3. Cole TJ,
   4. Baur X,
   5. Hall GL,
   6. Culver BH,
   7. et al

   . Multi-ethnic reference values for spirometry for the 3-95 year age range: the global lung function 2012 equations. Eur Respir J 2012;40(6):1324–1343.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Vaz Fragoso CA,
   2. Gill T

   . Respiratory Impairment and the aging lung: a novel paradigm for assessing pulmonary function. J Gerontol Med Sci 2012;67(3):264–275.

   OpenUrlPubMedWeb of Science
6. 6.↵
   1. Allen SC,
   2. Yeung P

   . Inability to draw intersecting pentagons as a predictor of unsatisfactory spirometry technique in elderly hospital inpatients. Age and Ageing 2006;35(3):304–306.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Weisman IM,
   2. Beck KC,
   3. Casaburi R,
   4. Cotes JE,
   5. Crapo RO,
   6. Dempsey JA,
   7. et al

   . ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003;167(2):211–277.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Vaz Fragoso CA,
   2. Beavers DP,
   3. Hankinson JL,
   4. Flynn G,
   5. Berra K,
   6. Kritchevsky SB,
   7. et al

   .; on behalf of the Lifestyle Interventions and Independence in Elder Study Group. Respiratory impairment and dyspnea and their associations with physical inactivity and mobility in sedentary community-dwelling older persons. J Am Geriatr Soc 2014;62(4):622–628.

   OpenUrlCrossRefPubMed
9. 9.
   1. Miner B,
   2. Tinetti ME,
   3. Van Ness PH,
   4. Han L,
   5. Leo-Summers L,
   6. Newman AB,
   7. et al

   . Dyspnea in community-dwelling older persons: a multifactorial geriatric health condition. J Am Geriatr Soc 2016;64(10):2042–2050.

   OpenUrl
10. 10.
    1. Studenski S,
    2. Perera S,
    3. Patel K,
    4. Rosano C,
    5. Faulkner K,
    6. Inzitari M,
    7. et al

    . Gait speed and survival in older adults. JAMA 2011;305(1):50–58.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Tessier JF,
    2. Nejjari C,
    3. Letenneur L,
    4. Filleul L,
    5. Marty ML,
    6. Gateau PB,
    7. Dartigues JF

    . Dyspnea and 8-year mortality among elderly men and women: The PAQUID cohort study. Eur J Epidemiol 2001;17(3):223–229.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Vaz Fragoso CA,
    2. McAvay G,
    3. Van Ness PH,
    4. Metter EJ,
    5. Ferrucci L,
    6. Yaggi HK,
    7. et al

    . Aging-related considerations when evaluating the forced expiratory volume in 1-second (FEV₁) over time. J Gerontol A Biol Sci Med Sci 2016;71(7):929–934.

    OpenUrlCrossRefPubMed
13. 13.
    1. Marcus EB,
    2. Curb JD,
    3. MacLean VJ,
    4. Reed DM,
    5. Yano K

    . Pulmonary function as a predictor of coronary heart disease. Am J Epidemiol 1989;129(1):97–104.

    OpenUrlPubMedWeb of Science
14. 14.
    1. Hole DJ,
    2. Watt GCM,
    3. Davey-Smith G,
    4. Hart CL,
    5. Gillis CR,
    6. Hawthorne VM

    . Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996;313(7059):711–716.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Min KB,
    2. Min JY

    . Reduced lung function, C-reactive protein, and increased risk of cardiovascular mortality. Circ J 2014;78(9):2309–2316.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Bapoje SR,
    2. Whitaker JF,
    3. Schulz T,
    4. Chu ES,
    5. Albert RK

    . Preoperative evaluation of the patient with pulmonary disease. Chest 2007;132(5):1637–1645.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Vogelmeier CF,
    2. Criner GJ,
    3. Martinez FJ,
    4. Anzueto A,
    5. Barnes PJ,
    6. Bourbeau J,
    7. et al

    . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med 2017;195(5):557–582.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Vaz Fragoso CA,
    2. McAvay G,
    3. Van Ness PH,
    4. Casaburi R,
    5. Jensen RL,
    6. MacIntyre N,
    7. et al

    . Phenotype of spirometric impairment in an aging population. Am J Respir Crit Care Med 2016;193(7):727–735.

    OpenUrlCrossRefPubMed
19. 19.
    1. Vaz Fragoso CA,
    2. Cain HC,
    3. Casaburi R,
    4. Lee PJ,
    5. Iannone L,
    6. Leo-Summers LS,
    7. Van Ness PH

    . Spirometry, static lung volumes, and diffusing capacity. Respir Care 2017;62(9):1137–1147.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Vaz Fragoso CA,
    2. Concato J,
    3. McAvay G,
    4. Van Ness PH,
    5. Gill TM

    . Respiratory impairment and COPD hospitalization: a competing risk analysis. Eur Respir J 2012;40(1):37–44.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Fried LP,
    2. Borhani NO,
    3. Enright P,
    4. Furberg CD,
    5. Gardin JM,
    6. Kronmal RA,
    7. et al

    ; on behalf of the Cardiovascular Health Study Research Group (CHS). The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991;1(3):263–276.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Murphy TE,
    2. McAvay G,
    3. Carriero NJ,
    4. Gross CP,
    5. Tinetti ME,
    6. Allore HG,
    7. Lin H

    . Deaths observed in Medicare beneficiaries: average attributable fraction and its longitudinal extension for many diseases. Statist Med 2012;31(27):3313–3319.

    OpenUrl
23. 23.↵
    1. Vaz Fragoso CA,
    2. Van Ness PH,
    3. Murphy TE,
    4. McAvay G

    . Spirometric impairments, cardiovascular outcomes, and noncardiovascular death in older persons. Respir Med 2018;137:40–47.

    OpenUrl
24. 24.↵
    1. Miller MR

    . Does the use of per cent of predicted have any evidence base? Eur Respir J 2015;45:322–323.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    1. Griffith KA,
    2. Sherrill DL,
    3. Siegel EM,
    4. Manolio TA,
    5. Bonekat HW,
    6. Enright PL

    . Predictors of loss of lung function in the elderly: the cardiovascular health study. Am J Respir Crit Care Med 2001;163(1):61–68.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    1. Vaz Fragoso CA,
    2. McAvay G,
    3. Van Ness PH,
    4. Casaburi R,
    5. Jensen RL,
    6. MacIntyre N,
    7. et al

    . Phenotype of normal spirometry in an aging population. Am J Respir Crit Care Med 2015;192(7):817–825.

    OpenUrlCrossRefPubMed
27. 27.↵
    1. Rich MW,
    2. Chyun D,
    3. Skolnick AH,
    4. Alexander KP,
    5. Forman DE,
    6. Kitzman DW,
    7. et al

    . Knowledge gaps in cardiovascular care of older adults: a scientific statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society. J Amer Geriatr Soc 2016;64(11):2185–2192.

    OpenUrl
28. 28.↵
    1. Miller MR,
    2. Pedersen OF

    . New concepts for expressing forced expiratory volume in 1 s arising from survival analysis. Eur Respir J 2010;35(4):873–882.

    OpenUrlAbstract/FREE Full Text
29. 29.↵
    1. Hankinson JL,
    2. Crapo RO,
    3. Jensen RL

    . Spirometric reference values for the 6-s FVC maneuver. Chest 2003;124(5):1805–1811.

    OpenUrlCrossRefPubMedWeb of Science
30. 30.↵
    1. Quanjer PH,
    2. Pretto JH,
    3. Brazzale DJ,
    4. Boros PW

    . Grading the severity of airways obstruction: new wine in new bottles. Eur Respir J 2014;43(2):505–512.

    OpenUrlAbstract/FREE Full Text
31. 31.↵
    1. Feinstein A

    . The inadequacy of binary models for the clinical reality of three-zone diagnostic decisions. J Clin Epidemiol 1990;43:109–113.

    OpenUrlCrossRefPubMedWeb of Science
32. 32.
    1. Quanjer PH,
    2. Ruppel G,
    3. Brusasco V,
    4. Pérez-Padilla R,
    5. Vaz Fragoso CA,
    6. Culver BH,
    7. et al

    . COPD [confusion over proper diagnosis] in the zone of maximum uncertainty (letter). Eur Respir J 2015;46:1523–1524.

    OpenUrlAbstract/FREE Full Text
33. 33.↵
    1. Cook NR

    . Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007;115:928–935.

    OpenUrlAbstract/FREE Full Text
34. 34.↵
    1. Vaz Fragoso CA,
    2. Concato J,
    3. McAvay G,
    4. Van Ness PH,
    5. Rochester CL,
    6. Yaggi HK,
    7. Gill TM

    . The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181:446–451.

    OpenUrlCrossRefPubMedWeb of Science
35. 35.↵
    1. Vaz Fragoso CA,
    2. Gill TM,
    3. McAvay G,
    4. Quanjer PH,
    5. Van Ness PH,
    6. Concato J

    . Respiratory impairment in older persons: when less means more. Am J Med 2013;126:49–57.

    OpenUrlCrossRefPubMed
36. 36.↵
    1. Fried TR,
    2. Vaz Fragoso CA,
    3. Rabow MW

    . Caring for the older person with chronic obstructive pulmonary disease. JAMA 2012;308(12):1254–1263.

    OpenUrlPubMed